Colonic Inertia Clinical Trial
— BenefiberOfficial title:
Effect of Wheat Dextrin on Calcium and Magnesium Absorption
Verified date | October 2010 |
Source | Creighton University |
Contact | n/a |
Is FDA regulated | No |
Health authority | United States: Institutional Review Board |
Study type | Interventional |
To compare calcium and magnesium absorption within subjects with and without chronic consumption of wheat dextrin.
Status | Completed |
Enrollment | 40 |
Est. completion date | October 2010 |
Est. primary completion date | June 2010 |
Accepts healthy volunteers | Accepts Healthy Volunteers |
Gender | Female |
Age group | 19 Years and older |
Eligibility |
Inclusion Criteria: - Subjects will be generally healthy Caucasian females aged 19 and older with no known abnormalities of gastrointestinal function, and taking no medications that might alter absorptive performance. BMI will be between 19 and 31 kg/m2 |
Allocation: Randomized, Endpoint Classification: Pharmacokinetics Study, Intervention Model: Crossover Assignment, Masking: Double Blind (Subject, Investigator), Primary Purpose: Treatment
Country | Name | City | State |
---|---|---|---|
n/a |
Lead Sponsor | Collaborator |
---|---|
Creighton University | Novartis |
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | Calcium Absorption | The calcium load to be tested will be 300 mg calcium from calcium and vitamin D fortified TropicanaTM orange juice extrinsically labeled with ˜3-7 µCi of 45Ca. The labeled orange juice will be ingested as part of a light meal, served as breakfast, after an overnight fast. | within 2-4 weeks | No |
Secondary | Magnesium absorption | The magnesium load to be tested will be from calcium and vitamin D fortified TropicanaTM orange juice extrinsically labeled with 30 mg 26Mg. The labeled orange juice will be ingested as part of a light meal, served as breakfast, after an overnight fast. | within 2-4 weeks | No |
Status | Clinical Trial | Phase | |
---|---|---|---|
Withdrawn |
NCT00949377 -
Can Methylnaltrexone Safely Treat Opioid Related Constipation in the Emergency Department?
|
Phase 4 |